MyAverix Finance
US · Healthcare
Luye Pharma Group Ltd (LYPHF)
Drug Manufacturers - Specialty & Generic
Luye Pharma Group Ltd (LYPHF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LYPHF
Luye Pharma Group Ltd (LYPHF) — FAQ
What is LYPHF's P/E ratio?
The price-to-earnings (P/E) ratio for Luye Pharma Group Ltd (LYPHF) is 18.00 (data as of 2026-05-23).
Does Luye Pharma Group Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Luye Pharma Group Ltd (LYPHF). Check the MyAverix Finance app for the latest dividend data.
What sector is Luye Pharma Group Ltd in?
Luye Pharma Group Ltd (LYPHF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is LYPHF listed on?
LYPHF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.